Research Roundtable

Through its Research Roundtable program, NBTS provides a means for regular and meaningful dialogue among a broad stakeholder community, including government, academia, the pharmaceutical industry, patients, and patient advocates to address the complex issues and identify actionable solutions.

The Research Roundtable is a mission-driven forum aimed at addressing current scientific, clinical, and regulatory needs, while promoting collaboration, appropriate information sharing, robust dialogue, and coalition building. It is critical that, together, we accelerate the development of new treatments to achieve better outcomes for patients.

Through the Research Roundtable, participants tackle specific issues, from identification of obstacles and barriers, to possible solutions—with the overall goal of advancing brain tumor research.

Past Roundtable Topics

Click on each link below for a short summary:

• December 2022 — Conducting Clinical Trials in Certain Front-Line Settings
• April 2022 — Update of the Response Assessment in Neuro-Oncology (RANO) Criteria & Discussion of Overall Response Rate (ORR)
• December 2021 — 2021 WHO Classification of Tumors of the Central Nervous System: Implications for Clinical Trials
• July 2021 — Use of External Control Arms in Pediatric Brain Tumor Trials
• December 2020 — Moving the Needle—Progress for Brain Tumor Clinical Trials
• July 2020 — Innovating Brain Tumor Clinical Trials: Building on Lessons Learned from COVID-19 Experience
• December 2019 — Process and Evidence Requirements for Developing a New Brain Tumor Endpoint
• December 2018 — Leveraging the Power of I-O to Treat Primary Brain Tumors
• July 2018 — Opportunities for Repurposing Drugs for Brain Tumors
• December 2017 — Improving Early Phase Clinical Trials to Accelerate Brain Tumor Drug Development
• June 2017 — Streamlining Clinical Trials to Accelerate Brain Tumor Drug Development

Research Roundtable Members